Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (22461)	6/18/1998 9:52:00 AM
From: Phil Cressman	Read Replies (1) \| Respond to of 32384

Henry I disagree, it's never good to chase people out of a stock, the more the merrier. However if they want to sell out cheap it certainly is a buying opportunity. I'm trying to pick up some SRGN at 52 cents right now because for some reason it was affected with a larger percentage drop. For some darn reason I don't trade LGND but don't mind doing the same with SRGN.

To: Henry Niman who wrote (22461)	6/18/1998 10:05:00 AM
From: Harold Engstrom	Read Replies (1) \| Respond to of 32384

This sequence of events is not common with well-run operations. Well planned and run cGMP facilities do not foster these problems. Saying that these problems are common or citing old analysts reports that cheer the advisory board meeting just amounts to chaff.